Format
Sort by
Items per page

Send to

Choose Destination

Search Tip

Sort by Best Match to display results from highest to lowest relevance to your search terms.

Try it Now

Search results

Items: 1 to 20 of 1580

1.
2.

Optical coherence tomography-guided PCI - Authors' reply.

Ali ZA, Maehara A, Mintz GS, Stone GW; ILUMIEN III: OPTIMIZE PCI Investigators..

Lancet. 2017 Apr 22;389(10079):1608. doi: 10.1016/S0140-6736(17)31018-8. No abstract available.

PMID:
28443553
3.

Comparison of Outcomes and Prognosis of Patients With Versus Without Newly Diagnosed Diabetes Mellitus After Primary Percutaneous Coronary Intervention for ST-Elevation Myocardial Infarction (the HORIZONS-AMI Study).

Ertelt K, Brener SJ, Mehran R, Ben-Yehuda O, McAndrew T, Stone GW.

Am J Cardiol. 2017 Mar 29. pii: S0002-9149(17)30339-9. doi: 10.1016/j.amjcard.2017.03.016. [Epub ahead of print]

PMID:
28427734
4.

Economic Outcomes of Bioresorbable Vascular Scaffolds Versus Everolimus-Eluting Stents in Patients Undergoing Percutaneous Coronary Intervention: 1-Year Results From the ABSORB III Trial.

Baron SJ, Lei Y, Chinnakondepalli K, Vilain K, Magnuson EA, Kereiakes DJ, Ellis SG, Stone GW, Cohen DJ; ABSORB III Investigators..

JACC Cardiovasc Interv. 2017 Apr 24;10(8):774-782. doi: 10.1016/j.jcin.2017.01.022.

5.

Bleeding-Related Deaths in Relation to the Duration of Dual-Antiplatelet Therapy After Coronary Stenting.

Palmerini T, Bacchi Reggiani L, Della Riva D, Romanello M, Feres F, Abizaid A, Gilard M, Morice MC, Valgimigli M, Hong MK, Kim BK, Jang Y, Kim HS, Park KW, Colombo A, Chieffo A, Ahn JM, Park SJ, Schüpke S, Kastrati A, Montalescot G, Steg PG, Diallo A, Vicaut E, Helft G, Biondi-Zoccai G, Xu B, Han Y, Genereux P, Bhatt DL, Stone GW.

J Am Coll Cardiol. 2017 Apr 25;69(16):2011-2022. doi: 10.1016/j.jacc.2017.02.029.

PMID:
28427576
6.

Infarct size, left ventricular function, and prognosis in women compared to men after primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: results from an individual patient-level pooled analysis of 10 randomized trials.

Kosmidou I, Redfors B, Selker HP, Thiele H, Patel MR, Udelson JE, Magnus Ohman E, Eitel I, Granger CB, Maehara A, Kirtane A, Généreux P, Jenkins PL, Ben-Yehuda O, Mintz GS, Stone GW.

Eur Heart J. 2017 Apr 12. doi: 10.1093/eurheartj/ehx159. [Epub ahead of print]

PMID:
28407050
7.

Relation of Baseline Hemoglobin Levels and Adverse Events in Patients With Acute Coronary Syndromes (from the Acute Catheterization and Urgent Intervention Triage strategY and Harmonizing Outcomes with RevasculariZatiON and Stents in Acute Myocardial Infarction Trials).

Brener SJ, Mehran R, Dangas GD, Ohman EM, Witzenbichler B, Zhang Y, Parvataneni R, Stone GW.

Am J Cardiol. 2017 Mar 16. pii: S0002-9149(17)30292-8. doi: 10.1016/j.amjcard.2017.02.052. [Epub ahead of print]

PMID:
28388994
8.

Characteristics of dyspnoea and associated clinical outcomes in the CHAMPION PHOENIX study.

Parker WA, Bhatt DL, Prats J, Day JR, Steg PG, Stone GW, Hamm CW, Mahaffey KW, Price MJ, Gibson CM, White HD, Storey RF; CHAMPION PHOENIX Investigators..

Thromb Haemost. 2017 Apr 6. doi: 10.1160/TH16-12-0958. [Epub ahead of print]

PMID:
28382371
9.

A randomised, double-blind, phase 3 study comparing the efficacy and safety of ceftazidime/avibactam plus metronidazole versus meropenem for complicated intra-abdominal infections in hospitalised adults in Asia.

Qin X, Tran BG, Kim MJ, Wang L, Nguyen DA, Chen Q, Song J, Laud PJ, Stone GG, Chow JW.

Int J Antimicrob Agents. 2017 May;49(5):579-588. doi: 10.1016/j.ijantimicag.2017.01.010. Epub 2017 Mar 29.

10.

Molecular β-lactamase characterization of aerobic Gram-negative pathogens recovered from patients enrolled in the ceftazidime-avibactam phase 3 trials for complicated intra-abdominal infections: Efficacies analyzed against susceptible and resistant subsets.

Mendes RE, Castanheira M, Woosley LN, Stone GG, Bradford PA, Flamm RK.

Antimicrob Agents Chemother. 2017 Mar 27. pii: AAC.02447-16. doi: 10.1128/AAC.02447-16. [Epub ahead of print]

PMID:
28348155
11.

Bioprosthetic surgical and transcatheter heart valve thrombosis.

Bax JJ, Stone GW.

Lancet. 2017 Mar 17. pii: S0140-6736(17)30764-X. doi: 10.1016/S0140-6736(17)30764-X. [Epub ahead of print] No abstract available.

PMID:
28330691
12.

Platelets Cellular and Functional Characteristics in Patients with Atrial Fibrillation: A Comprehensive Meta-Analysis and Systematic Review.

Weymann A, Ali-Hasan-Al-Saegh S, Sabashnikov A, Popov AF, Mirhosseini SJ, Nombela-Franco L, Testa L, Lotfaliani M, Zeriouh M, Liu T, Dehghan H, Yavuz S, de Oliveira Sá MP, Baker WL, Jang JS, Gong M, Benedetto U, Dohmen PM, D'Ascenzo F, Deshmukh AJ, Biondi-Zoccai G, Calkins H, Stone GW, Surgery And Cardiology-Group Imcsc-Group IM.

Med Sci Monit Basic Res. 2017 Mar 17;23:58-86.

13.

Reply: Characteristic Left Ventricular Regional Wall Motion Abnormality Can Help Prevent Unnecessary Ischemic Workup.

Doshi D, Ben-Yehuda O, Bonafede M, Josephy N, Karmpaliotis D, Parikh MA, Moses JW, Stone GW, Leon MB, Schwartz A, Kirtane AJ.

J Am Coll Cardiol. 2017 Mar 21;69(11):1517-1518. doi: 10.1016/j.jacc.2016.12.032. No abstract available.

PMID:
28302298
14.

Impact of Chronic Total Occlusions on Revascularization Scores and Outcome Prediction.

Redfors B, Palmerini T, Caixeta A, Ayele GM, Francese DP, Mehran R, Brilakis ES, Kirtane AJ, Karmpaliotis D, Stone GW, Généreux P.

J Invasive Cardiol. 2017 Apr;29(4):123-131. Epub 2017 Mar 15.

15.

Everolimus-Eluting Stents or Bypass Surgery for Left Main Coronary Disease.

Stone GW, Sabik JF, Serruys PW, Kappetein AP.

N Engl J Med. 2017 Mar 16;376(11):1089. doi: 10.1056/NEJMc1701177. No abstract available.

16.

Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.

Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators..

Lancet. 2017 Mar 11;389(10073):1025-1034. doi: 10.1016/S0140-6736(17)30397-5.

PMID:
28290994
17.

Platelet Reactivity and Clinical Outcomes After Coronary Artery Implantation of Drug-Eluting Stents in Subjects With Peripheral Arterial Disease: Analysis From the ADAPT-DES Study (Assessment of Dual Antiplatelet Therapy With Drug-Eluting Stents).

Gupta R, Kirtane AJ, Ozan MO, Witzenbichler B, Rinaldi MJ, Metzger DC, Weisz G, Stuckey TD, Brodie BR, Mehran R, Ben-Yehuda O, Stone GW.

Circ Cardiovasc Interv. 2017 Mar;10(3). pii: e004904. doi: 10.1161/CIRCINTERVENTIONS.116.004904.

PMID:
28288963
18.

Defect Coupling and Sub-Angstrom Structural Distortions in W1-xMoxS2 Monolayers.

Azizi A, Wang Y, Stone G, Elias AL, Lin Z, Terrones M, Crespi VH, Alem N.

Nano Lett. 2017 Apr 13. doi: 10.1021/acs.nanolett.6b05045. [Epub ahead of print]

PMID:
28288273
19.

Coronary Plaque Characteristics in Hemodialysis-Dependent Patients as Assessed by Optical Coherence Tomography.

Chin CY, Matsumura M, Maehara A, Zhang W, Lee CT, Yamamoto MH, Song L, Parviz Y, Jhalani NB, Mohan S, Ratner LE, Cohen DJ, Ben-Yehuda O, Stone GW, Shlofmitz RA, Kakuta T, Mintz GS, Ali ZA.

Am J Cardiol. 2017 May 1;119(9):1313-1319. doi: 10.1016/j.amjcard.2017.01.022. Epub 2017 Feb 9.

PMID:
28279437
20.

Incidence, Predictors, and Outcomes of High-Grade Atrioventricular Block in Patients With ST-Segment Elevation Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention (from the HORIZONS-AMI Trial).

Kosmidou I, Redfors B, Dordi R, Dizon JM, McAndrew T, Mehran R, Ben-Yehuda O, Mintz GS, Stone GW.

Am J Cardiol. 2017 May 1;119(9):1295-1301. doi: 10.1016/j.amjcard.2017.01.019. Epub 2017 Feb 16.

PMID:
28267964

Supplemental Content

Loading ...
Support Center